Gain Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Gain Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2020 to Q3 2024.
  • Gain Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 26M shares, a 103% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 26M +13.2M +103% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 25.2M +12.5M +99.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 18M +5.95M +49.3% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 16.2M +4.32M +36.4% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 12.8M +899K +7.57% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 12.6M +749K +6.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 12.1M +204K +1.72% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 11.9M 0 0% Dec 31, 2022 10-K 2024-03-26
Q3 2022 11.9M +3.63K +0.03% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 11.9M +6.91K +0.06% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 11.9M +6.91K +0.06% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 11.9M +8.34M +235% Dec 31, 2021 10-K 2023-03-23
Q3 2021 11.9M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 11.9M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 11.9M Mar 31, 2021 10-Q 2021-05-10
Q4 2020 3.54M Dec 31, 2020 10-K 2022-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.